Skip to main content
logo
aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.1700
-0.0023 (-1.33%)
At close: Oct 22, 2026, 4:00 PM EDT
0.1764
+0.0064 (3.76%)
After-hours: Oct 22, 2026, 6:37 PM EDT

aTyr Pharma Revenue

In the year 2025, aTyr Pharma had annual revenue of $190.00K, down -19.15%. That makes aTyr Pharma the 45,505th largest company in the world by revenue and 6,639th in the United States.

Revenue (ttm)
$190.00K
Revenue Growth
-19.15%
P/S Ratio
88.07
Revenue / Employee
$3,167
Employees
60
Market Cap
16.67M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025190.00K-45.00K-19.15%
Dec 31, 2024235.00K-118.00K-33.43%
Dec 31, 2023353.00K-10.03M-96.60%
Dec 31, 202210.39M--
Dec 31, 2021---
Dec 31, 202010.46M10.03M2,377.49%
Dec 31, 2019422.00K--
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
TScan Therapeutics7.11M
Marker Therapeutics3.55M
SeaStar Medical Holding1.71M
Neuphoria Therapeutics1.17M
Cocrystal Pharma330.00K
Fractyl Health3.00K
BioCardia3.00K
Revenue Rankings

ATYR News

More News